Epidemiology, risk factors and surveillance of hepatocellular carcinoma

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 4, 2010, Pages 352-355

  Cabibbo, Giuseppe ^a   Craxi A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Hepatocellular carcinoma; Risk factors; Screening; Surveillance

Indexed keywords

ALPHA FETOPROTEIN;

CANCER SCREENING; CANCER SURVIVAL; DISEASE SURVEILLANCE; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; REVIEW; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 77953156245     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. PARKIN DM, BRAY F, FERLAY J, PISANI P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. BRUIX J, SHERMAN M; PRACTICE GUIDELINES COMMITTEE, AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236.
3. PARKIN DM, BRAY FI, DEVESA SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37(Suppl8): S4-66.
4. EL-SERAG HB, RUDOLPH KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
5. EL-SERAG HB, MASON AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160: 3227-3230.
6. HASSAN MM, HWANG LY, HATTEN CJ, SWAIM M, LI D, ABBRUZZESE JL, BEASLEY P, PATT YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002; 36: 1206-1213.
7. BUGIANESI E, LEONE N, VANNI E, MARCHESINI G, BRUNELLO F, CARUCCI P, MUSSO A, DE PAOLIS P, CAPUSSOTTI L, SALIZZONI M, RIZZETTO M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-140.
8. CALLE EE, RODRIGUEZ C, WALKER-THURMOND K, THUN MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
9. BUGIANESI E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007; 11: 191-207, x-xi.
10. BRUIX J, SHERMAN M, LLOVET JM, BEAUGRAND M, LENCIONI R, BURROUGHS AK, CHRISTENSEN E, PAGLIARO L, COLOMBO M, RODÉS J; EASL PANEL OF EXPERTS ON HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430.
11. KUDO M, OKANOUE T; JAPAN SOCIETY OF HEPATOLOGY. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007; 72(Suppl 1): 2-15.
12. BOLONDI L, SOFIA S, SIRINGO S, GAIANI S, CASALI A, ZIRONI G, PISCAGLIA F, GRAMANTIERI L, ZANETTI M, SHERMAN M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259.
13. ZHANG BH, YANG BH, TANG ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422.
14. SAAB S, LY D, NIETO J, KANWAL F, LU D, RAMAN S, AMADO R, NUESSE B, DURAZO F, HAN S, FARMER DG, GHOBRIAL RM, YERSIZ H, CHEN P, SCHWEGEL K, GOLDSTEIN LI, TONG M, BUSUTTIL RW. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model. Liver Transpl 2003; 9: 672-681.
15. SHERMAN M, PELTEKIAN KM, LEE C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432-438.
16. PATERON D, GANNE N, TRINCHET JC, AUROUSSEAU MH, MAL F, MEICLER C, CODERC E, REBOULLET P, BEAUGRAND M. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20: 65-71.
17. SANGIOVANNI A, DEL NINNO E, FASANI P, DE FAZIO C, RONCHI G, ROMEO R, MORABITO A, DE FRANCHIS R, COLOMBO M. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004; 126: 1005-1014. (Pubitemid 38451172)
18. STRAVITZ RT, HEUMAN DM, CHAND N, STERLING RK, SHIFFMAN ML, LUKETIC VA, SANYAL AJ, HABIB A, MIHAS AA, GILES HC, MALUF DG, COTTERELL AH, POSNER MP, FISHER RA. Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med 2008; 121: 119-126. (Pubitemid 351199465)
19. THOMPSON COON J, ROGERS G, HEWSON P, WRIGHT D, ANDERSON R, CRAMP M, JACKSON S, RYDER S, PRICE A, STEIN K. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess 2007; 11: 1-206.
20. SHEU JC, SUNG JL, CHEN DS, YANG PM, LAI MY, LEE CS, HSU HC, CHUANG CN, YANG PC, WANG TH, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89: 259-266.
21. BARBARA L, BENZI G, GAIANI S, FUSCONI F, ZIRONI G, SIRINGO S, RIGAMONTI A, BARBARA C, GRIGIONI W, MAZZIOTTI A, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137.
22. TREVISANI F, DE NS, RAPACCINI G, FARINATI F, BENVEGNÙ L, ZOLI M, GRAZI GL, DEL PP, DI N, BERNARDI M; ITALIAN LIVER CANCER GROUP. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002; 97: 734-744.
23. SANTAGOSTINO E, COLOMBO M, RIVI M, RUMI MG, ROCINO A, LINARI S, MANNUCCI PM; STUDY GROUP OF THE ASSOCIATION OF ITALIAN HEMOPHILIA CENTERS. A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus. Blood 2003; 102: 78-82.
24. SANTI V, TREVISANI F, DEL POGGIO P, DI NOLFO MA, BENVEGNÙ L, FARINATI F, ZOLI M, GIANNINI EG, BORZIO F, CATURELLI E, CHIARAMONTE M, BERNARDI M, FOR ITALIAN LIVER CANCER (ITA.LI.CA) GROUP. Semiannual versus annual surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma: is there a winner? Digestive and Liver Disease 2009; 41: A5-A6.
25. KIM DY, HAN KH, AHN SA, PIK YH, LEE KS, CHON CY, MOON YM. Semiannual surveillance for hepatocellular carcinoma improved patient survival compared to annual surveillance (Korean experience). [Abstract]. Hepatology 2007; 46 (Suppl): 403A.
26. TRINCHET J, BEAUGRAND M FROM GRETCH. A randomized trial comparing 3-month vs. 6-month screening for HCC by ultrasonography in cirrhosis. Book of Abstract-International Liver Cancer Association (ILCA), 2007.